KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Change in Receivables (2016 - 2025)

Humana (HUM) has disclosed Change in Receivables for 16 consecutive years, with -$1.8 billion as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables changed N/A to -$1.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 billion, a N/A change, with the full-year FY2024 number at $669.0 million, up 98.52% from a year prior.
  • Change in Receivables was -$1.8 billion for Q3 2025 at Humana, down from $45.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.8 billion in Q1 2025 to a low of -$1.8 billion in Q3 2025.
  • A 4-year average of $145.9 million and a median of $150.5 million in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: crashed 566.67% in 2021, then soared 564.29% in 2022.
  • Humana's Change in Receivables stood at -$14.0 million in 2021, then skyrocketed by 564.29% to $65.0 million in 2022, then soared by 2104.62% to $1.4 billion in 2023, then plummeted by 226.73% to -$1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Change in Receivables are -$1.8 billion (Q3 2025), $45.0 million (Q2 2025), and $1.8 billion (Q1 2025).